Gliclazide scavenges hydroxyl, superoxide and nitric oxide radicals: An esr study

Research Communications in Molecular Pathology and Pharmacology

Volumn 96, Issue 2, 1997, Pages 115-124

  Noda, Yasuko ^a   Mori, Akitane ^a   Packer, Lester ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLICLAZIDE; HYDROXYL RADICAL; NITRIC OXIDE; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; SUPEROXIDE DISMUTASE;

ARTICLE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DOSE RESPONSE; DRUG EFFECT; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; IN VITRO STUDY; INSULIN RELEASE; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICAL SCAVENGERS; FREE RADICALS; GLICLAZIDE; GLYBURIDE; HYPOGLYCEMIC AGENTS; NITRIC OXIDE; OXIDATIVE STRESS; SUPEROXIDES;

EID: 0030857430     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Arai, K., Iizuka, S., Tada, Y., Oikawa, K. and Taniguchi, N. (1987) Increase in the glucosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glucosylation with the enzyme activity. Biochim. Biophys. Acta 924: 292-296.
2. Belch, J. J., Mackay, I. R., Hill, A., Jennings, P., McCollum, P. (1995) Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus. Int. Angiol. 14: 385-388.
3. Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P. and Cerami, A. (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232: 1629-1632.
4. Bucala, R., Tracey, K. J. and Carami, A. (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J. Clin. Invest. 87: 432-438.
5. Cameron, N. E., Cotter, M. A. (1995a) Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J. Clin. Invest. 96: 1159-1163.
6. Cameron, N. E., Cotter, M. A. (1995b) Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats. Naunyn-Schmiedebergs Arch. Pharmacol. 352:685-690.
7. Cameron, N. E., Cotter, M. A. (1996c) Rapid reversal by aminoguanidine of the neurovascùlar effects of diabetes in rats: modulation by nitric oxide synthase inhibition. Metabolism: Clin. Exp. 45: 1147-1152.
8. Collier, A., Wilson, H., Bradley, J. A. and Small, M. (1990) Free radical activity in type II diabetes. Diabetic Med. 7: 27-30.
9. Cotter, M. A., Love, A., Watt, M. J., Cameron, N. E., Dines, K. C. (1995) Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 38: 1285-1294.
10. Forsberg, H., Borg, L. A., Cagliero, E., Eriksson, U. J. (1996) Altered levels of scavenging enzymes in embryos subjected to a diabetic environment. Free Radical Res. 24: 451-159.
11. Gillery, P., Monboisse, J. C., Maquart, F. X. and Borel, J. P. (1988) Glycation of proteins as a source of superoxide. Diabetes Metab. 14: 25-30.
12. Hames, H., Martin, S., Federlin, K., Geisen, K. and Brownlee, M (1991) Aminoguanidine inhibits the development of experimental diabetic retinopathy. Proc. Natl. Acad. Sci. USA 88: 11555-11558.
13. Harding, J. J. (1985) Nonenzymatic covalent posttranslation modification of proteins in vivo. Adv. Protein Chem. 37: 247-334.
14. Huijberts, M. S. P., Wolffenbutel, B. H. R., Boudier, H. A., Cijns, F. R. , Kruseman, A. C. N., Poitevin, P. and Levy, B. I. (1993) Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J. Clin. Invest. 92: 1407-1411.
15. Janzen, E. G. (1971) Spin trapping accounts. Chem. Res. 4: 31-40.
16. Jennings, P. E., Jones, C. M., Florkowski, J. , Lunce, J. and Barnett, A. H. (1987) Increased diene conjugates in diabetic subjects with microangiopathy. Diabetic Med. 4: 452-456.
17. Jennings, P. E., Scott, N. A., Saniabadi, A. R. and Belch, J. J. F. (1992) Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patiants: clinical assessment. Metabolism 41: 36-39.
18. Lagercrantz, C. (1971) Spin trapping of some short-lived radicals by the nitroxide method. J. Phys. Chem. 75: 3466-3474.
19. Lal, L., Chithra, P., Chandrakasan, G. (1996) The possible relevance of autoxidative glycosylation in glucose mediated alterations of proteins: an in vivo study on myofibrillar proteins. Mol. Cell. Biochem. 154: 95-100.
20. Liu, J., Edamatsu, R., Kabuto, H. and Mori, A. (1990) Antioxidant action of guilingji in the brain of rats with FeC13-induced epilepsy. Free Rad. Biol. Med. 9: 451-454.
21. Love, A., Cotter, M. A. and Cameron, N. E. (1996a) Effects of the sulphydryl donor N-acetyl-L-cyteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats. Eur. J. Clin. Invest. 26: 698-706.
22. Love, A., Cotter, M. A. and Cameron, N. E. (1996b) Nerve function and regeneration in diabetic and galactosaemic rats: antioxidant and metal chelator effects. Eur. J. Pharmacol. 314: 33-39.
23. Mooradian, A. D. (1995) The antioxidative potential of cerebral microvessels in experimental diabetes mellitus. Brain Res. 671: 164-169.
24. 1. Neurosciences 15: 371-376.
25. Mullarkey, C. J., Edelstein, D. and Brownlee, M. (1990) Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 173: 932-939.
26. Nath, N., Chari, S. N. and Rathi, A. B. (1984) Superoxide dismutase in diabetic polymorphonuclear leukocytes. Diabetes 33: 586-588.
27. Noda, Y., Anzai, K., Mori, A., Kohno, M., Shimmei, . and Packer, L. (1997) Hydroxyl radical and superoxide anion radical scavenging activities of natural antioxidants using the computerized JES-FR 30 ESR spectrometer system. Biochem. Mol. Biol. Int. (In press)
28. Ogata, K. (1986) Phosphoric acid diesters or thier salts and process for producing the same, U.S. Patent # 4,564,686.
29. Rosen, G. M. and Rauckman, E. J. (1984) Spin trapping of superoxide and hydroxyl radicals. In: Packer L. (ed.) Vol. 105 pp. 198-209, Methods in Enzymology, San Diego, Academic Press.
30. Sakurai, T. and Tsuchiya, S. (1988) Superoxide production from nonenzymatic glycated protein. FEBS Lett. 236: 406-410.
31. Sakurai, T., Sugioka, K. and Nakano, M. (1990) Superoxide generation and lipid peroxidation during the oxidation of a glycated peptide, glycated polylysine, in the presence of iron-ADP. Biochim. Biophys. Acta 1043: 27-33.
32. Scott, N. A., Jennings, P. E., Brown, J. and Belch, J. J. F. (1991) Gliclazide: a general free radical scavenger. Eur. J. Pharmacol. 208: 175-177.
33. Soiulis-Liparota, T., Cooper, M., Papazoglou, D., Clarke, B. and Jerums, G. (1991) Retardation by aminoguanidine of the development of albuminuria, mesangial expansion and tissue fluorescence in streptozotocin-induced diabetic rats Diabetes 40: 1328-1334.
34. Sumonski, W., Baquerizo, H. and Robinovitch, A. (1989) Oxygen free radical scavenging protects rat islet cells from damage by cytokines. Diabetologia 32-792-796.
35. Wolff, S. P. (1987) The potential role of oxidative stress in diabetes and its complications: novel implication for theory and therapy, In: Diabetic Complications. Edited by: Crabbe, M. J. C., Churchill-Livingstone, Edinburgh. pp. 167-220.